Safety Study of Pioglitazone Compared To Glyburide on Liver Function

NCT00494312 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2120

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Liver

Interventions

DRUG: Pioglitazone
DRUG: Glyburide

Sponsor

Takeda